CorMedix logo

CorMedix (CRMD) Q1 2026 Earnings

CRMD·Reported May 14, 2026·Before market open

CorMedix reported Q1 2026 revenue of $127.4M (+226.0% YoY), beat analyst consensus of $105.0M by $22.4M. Diluted EPS came in at $0.43 (+43.3% YoY), beat the $0.35 consensus by $0.08.

Revenue
$127.4Mbeat by $22.4M
Consensus: $105.0M
Diluted EPS
$0.43beat by $0.08
Consensus: $0.35
SEC

SEC Filings

Earnings release8-K · 0001410098-26-000020
Quarterly report10-Q · 0001410098-26-000021

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about CorMedix's Q1 2026 earnings report.

CorMedix (CRMD) reported Q1 2026 earnings on May 14, 2026 before market open.

CorMedix reported revenue of $127.4M and diluted EPS of $0.43 for Q1 2026.

Revenue beat the consensus estimate of $105.0M by $22.4M. EPS beat the consensus estimate of $0.35 by $0.08.

Compared to the same quarter a year prior, revenue grew 226.0% from $39.1M a year earlier and diluted EPS grew 43.3% from $0.30.

You can read the 8-K earnings release (0001410098-26-000020) and the 10-Q periodic report (0001410098-26-000021) directly on SEC EDGAR. The filing index links above go to sec.gov.